The Journal of Heart and Lung Transplantation
Volume 23, Issue 12 , Pages 1414-1422 , December 2004

Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving β-blockers

  • Todd M. Koelling, MD (FACC)

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
    • Corresponding Author InformationReprint requests: Todd M. Koelling, MD, 1500 E Medical Center Drive, Women’s L3623, 0271, Ann Arbor, MI 48109 USA. Telephone: 734-936-5265. Fax: 734-615-3326
  • ,
  • Susan Joseph, MD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
  • ,
  • Keith D. Aaronson, MD

      Affiliations

    • Department of Internal Medicine, Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA

Received 15 July 2003 ,Revised 1 October 2003 ,Accepted 22 October 2003.

References 

  1. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667
  2. United Network for Organ Sharing (UNOS) . Adult patient survival for heart transplants performed 1995 to 1998 (National Results). 2002; Available at: http:www.unos.org
  3. Packer M, Bristow MR, Cohn JN, et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–1355
  4. MERIT-HF Study Group . Effect of metoprolol CR/XL in chronic heart failure (Metoprolol cr/xl randomised intervention trial in congestive heart failure (merit-hf)). Lancet. 1999;353(9169):2001–2007
  5. CIBIS-II Investigators and Committees . The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) (A randomised trial). Lancet. 1999;353(9146):9–13
  6. Packer M, Coats AJ, Fowler MB, et al.  Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658
  7. Hunt SA, Baker DW, Chin MH, et al.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult (Executive summary). J Am Coll Cardiol. 2001;38:2101–2113
  8. Leung WH, Lau CP, Wong CK, Cheng CH, Tai YT, Lim SP. Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1990;119:884–890
  9. Andersson B, Blomstrom-Lundqvist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 1991;18:1059–1066
  10. Andersson B, Hamm C, Persson S, et al.  Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 1994;23:1397–1404
  11. Clements IP, Miller WL. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy. Am Heart J. 2001;141:259
  12. Pohwani AL, Murali S, Mathier MM, et al.  Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant. 2003;22:78–86
  13. Peterson LR, Schechtman KB, Ewald GA, et al.  The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant. 2003;22:70–77
  14. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol. 1986;60:2020–2027
  15. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  16. Rosenbaum P, Rubin D. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–524

PII: S1053-2498(03)00522-9

doi: 10.1016/j.healun.2003.10.002

The Journal of Heart and Lung Transplantation
Volume 23, Issue 12 , Pages 1414-1422 , December 2004